|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income: | |||||
| Other income | |||||
| Interest income | |||||
| Interest and other expense | |||||
| Total other income (expense) | |||||
| Net loss and comprehensive loss | |||||
| Net loss per share attributable to common stockholders: Basic | |||||
| Net loss per share attributable to common stockholders: diluted | |||||
| Weighted average shares outstanding: Basic | |||||
| Weighted average shares outstanding: diluted | |||||
| Unrealized gain (loss) on short-term investments | |||||
| Comprehensive loss |
Loading...
